Inotuzumab Ozogamicin Injection
225 interactions 104 cited referencesInotuzumab ozogamicin injection is used to treat certain acute lymphoblastic leukemia (ALL; a type of cancer that begins in the white blood cells) in adults who have not responded to previous cancer treatments. Inotuzumab ozogamicin injection is in a class of medications called monoclonal antibodies. It works by activa… Read the full Inotuzumab Ozogamicin Injection drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Inotuzumab Ozogamicin Injection Taletrectinib Ibtrozi Increased risk of QT interval prolongation and torsade de pointes Details Inotuzumab Ozogamicin Injection Tamoxifen Nolvadex® Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Telaprevir Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Telavancin Vibativ Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Telithromycin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Tetrabenazine Xenazine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Tolterodine Detrol Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Toremifene Fareston Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Trazodone Raldesy Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Triclabendazole Egaten An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Trimipramine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Triptorelin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Vandetanib Caprelsa Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Vardenafil Levitra Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Vemurafenib Zelboraf Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Venlafaxine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Vepdegestrant Veppanu An increased risk of QT interval prolongation and an increased risk of torsade de pointes, polymorphic ventricular tachycardia, ot... Details Inotuzumab Ozogamicin Injection Vilanterol Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Vinflunine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Voclosporin Lupkynis An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Voriconazole Vfend Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Vorinostat Zolinza Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Ziftomenib Komzifti An increased risk of QT interval prolongation and torsade de pointes Details Inotuzumab Ozogamicin Injection Zotepine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Zuclopenthixol Increased risk of QT interval prolongation DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist